Current Medicinal Chemistry
Title:Meet Our Editorial Board Member
Volume: 23 Issue: 41
Author(s): Isabel Haro
Affiliation:
Export Options
About this article
Cite this article as:
Haro Isabel, Meet Our Editorial Board Member, Current Medicinal Chemistry 2016; 23 (41) . https://dx.doi.org/10.2174/092986732341161223101620
DOI https://dx.doi.org/10.2174/092986732341161223101620 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
26
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Potential Drugs for the Treatment of COVID-19: Synthesis, Brief History and Application
Current Drug Research Reviews CuAAC Click Chemistry Accelerates the Discovery of Novel Chemical Scaffolds as Promising Protein Tyrosine Phosphatases Inhibitors
Current Medicinal Chemistry Therapeutic Antibodies in HIV Treatment - Classical Approaches to Novel Advances
Current Pharmaceutical Design Therapeutic Antibodies
Drug Design Reviews - Online (Discontinued) Recent Patents on the Synthesis and Application of Silica Nanoparticles for Drug Delivery
Recent Patents on Biotechnology Medicinal Chemistry of Selective Neurokinin-1 Antagonists
Current Topics in Medicinal Chemistry Active Immunization Against Tumor Necrosis Factor-alpha Decreases Proinflammatory Cytokines, Oxidative Stress Mediators and Adhesion Molecules Risk Factors in Streptozotocin-induced Diabetic Rats
Endocrine, Metabolic & Immune Disorders - Drug Targets Immunomodulatory Activity of MicroRNAs: Potential Implications for Multiple Myeloma Treatment
Current Cancer Drug Targets Cell Therapies for IBD: What Works?
Current Drug Targets MIF and CD74 - Suitability as Clinical Biomarkers
Mini-Reviews in Medicinal Chemistry The Development of MetAP-2 Inhibitors in Cancer Treatment
Current Medicinal Chemistry Biosimilars: From Extrapolation into Off Label Use
Current Pharmaceutical Design Geriatric Depression - Review for Primary Care
Current Psychiatry Reviews The Discovery of Novel Chemotypes of p38 Kinase Inhibitors
Current Topics in Medicinal Chemistry The Anti-Inflammatory Role of Annexin-1 in Arthritis
Current Rheumatology Reviews New Organ-Specific Pharmacological Strategies Interfering With Signaling Pathways In Inflammatory Disorders/Autoimmune Disorders
Current Signal Transduction Therapy Development and Optimization of Sustained Release Moxifloxacin Hydrochloride Loaded Nanoemulsion for Ophthalmic Drug Delivery: A 3<sup>2</sup> Factorial Design Approach
Micro and Nanosystems The Dramatic Role of IFN Family in Aberrant Inflammatory Osteolysis
Current Gene Therapy Imaging Epigenetics in Alzheimer’s Disease
Current Pharmaceutical Design Pharmacological Modulation of Th17
Recent Patents on Inflammation & Allergy Drug Discovery